New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient

Background: Focal segmental glomerulosclerosis (FSGS) is a kidney disease that is commonly associated with proteinuria and the progressive loss of renal function, which is characterized by podocyte injury and the depletion and collapse of glomerular capillary segments. The pathogenesis of FSGS has n...

Full description

Bibliographic Details
Main Authors: Cheng-Cheng Song, Quan Hong, Xiao-Dong Geng, Xu Wang, Shu-Qiang Wang, Shao-Yuan Cui, Man-Di Guo, Ou Li, Guang-Yan Cai, Xiang-Mei Chen, Di Wu
Format: Article
Language:English
Published: Wolters Kluwer 2018-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2666;epage=2675;aulast=Song
_version_ 1811331478546546688
author Cheng-Cheng Song
Quan Hong
Xiao-Dong Geng
Xu Wang
Shu-Qiang Wang
Shao-Yuan Cui
Man-Di Guo
Ou Li
Guang-Yan Cai
Xiang-Mei Chen
Di Wu
author_facet Cheng-Cheng Song
Quan Hong
Xiao-Dong Geng
Xu Wang
Shu-Qiang Wang
Shao-Yuan Cui
Man-Di Guo
Ou Li
Guang-Yan Cai
Xiang-Mei Chen
Di Wu
author_sort Cheng-Cheng Song
collection DOAJ
description Background: Focal segmental glomerulosclerosis (FSGS) is a kidney disease that is commonly associated with proteinuria and the progressive loss of renal function, which is characterized by podocyte injury and the depletion and collapse of glomerular capillary segments. The pathogenesis of FSGS has not been completely elucidated; however, recent advances in molecular genetics have provided increasing evidence that podocyte structural and functional disruption is central to FSGS pathogenesis. Here, we identified a patient with FSGS and aimed to characterize the pathogenic gene and verify its mechanism. Methods: Using next-generation sequencing and Sanger sequencing, we screened the causative gene that was linked to FSGS in this study. The patient's total blood RNA was extracted to validate the messenger RNA (mRNA) expression of coenzyme Q10 monooxygenase 6 (COQ6) and validated it by immunohistochemistry. COQ6 knockdown in podocytes was performed in vitro with small interfering RNA, and then, F-actin was determined using immunofluorescence staining. Cell apoptosis was evaluated by flow cytometry, the expression of active caspase-3 was determined by Western blot, and mitochondrial function was detected by MitoSOX. Results: Using whole-exome sequencing and Sanger sequencing, we screened a new causative gene, COQ6, NM_182480: exon1: c.G41A: p.W14X. The mRNA expression of COQ6 in the proband showed decreased. Moreover, the expression of COQ6, which was validated by immunohistochemistry, also had the same change in the proband. Finally, we focused on the COQ6 gene to clarify the mechanism of podocyte injury. Flow cytometry showed significantly increased in apoptotic podocytes, and Western blotting showed increases in active caspase-3 in si-COQ6 podocytes. Meanwhile, reactive oxygen species (ROS) levels were increased and F-actin immunofluorescence was irregularly distributed in the si-COQ6 group. Conclusions: This study reported a possible mechanism for FSGS and suggested that a new mutation in COQ6, which could cause respiratory chain defect, increase the generation of ROS, destroy the podocyte cytoskeleton, and induce apoptosis. It provides basic theoretical basis for the screening of FSGS in the future.
first_indexed 2024-04-13T16:21:04Z
format Article
id doaj.art-b569ae70bc7a42ba9b1727afc520c30a
institution Directory Open Access Journal
issn 0366-6999
2542-5641
language English
last_indexed 2024-04-13T16:21:04Z
publishDate 2018-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj.art-b569ae70bc7a42ba9b1727afc520c30a2022-12-22T02:39:56ZengWolters KluwerChinese Medical Journal0366-69992542-56412018-01-01131222666267510.4103/0366-6999.245158New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis PatientCheng-Cheng SongQuan HongXiao-Dong GengXu WangShu-Qiang WangShao-Yuan CuiMan-Di GuoOu LiGuang-Yan CaiXiang-Mei ChenDi WuBackground: Focal segmental glomerulosclerosis (FSGS) is a kidney disease that is commonly associated with proteinuria and the progressive loss of renal function, which is characterized by podocyte injury and the depletion and collapse of glomerular capillary segments. The pathogenesis of FSGS has not been completely elucidated; however, recent advances in molecular genetics have provided increasing evidence that podocyte structural and functional disruption is central to FSGS pathogenesis. Here, we identified a patient with FSGS and aimed to characterize the pathogenic gene and verify its mechanism. Methods: Using next-generation sequencing and Sanger sequencing, we screened the causative gene that was linked to FSGS in this study. The patient's total blood RNA was extracted to validate the messenger RNA (mRNA) expression of coenzyme Q10 monooxygenase 6 (COQ6) and validated it by immunohistochemistry. COQ6 knockdown in podocytes was performed in vitro with small interfering RNA, and then, F-actin was determined using immunofluorescence staining. Cell apoptosis was evaluated by flow cytometry, the expression of active caspase-3 was determined by Western blot, and mitochondrial function was detected by MitoSOX. Results: Using whole-exome sequencing and Sanger sequencing, we screened a new causative gene, COQ6, NM_182480: exon1: c.G41A: p.W14X. The mRNA expression of COQ6 in the proband showed decreased. Moreover, the expression of COQ6, which was validated by immunohistochemistry, also had the same change in the proband. Finally, we focused on the COQ6 gene to clarify the mechanism of podocyte injury. Flow cytometry showed significantly increased in apoptotic podocytes, and Western blotting showed increases in active caspase-3 in si-COQ6 podocytes. Meanwhile, reactive oxygen species (ROS) levels were increased and F-actin immunofluorescence was irregularly distributed in the si-COQ6 group. Conclusions: This study reported a possible mechanism for FSGS and suggested that a new mutation in COQ6, which could cause respiratory chain defect, increase the generation of ROS, destroy the podocyte cytoskeleton, and induce apoptosis. It provides basic theoretical basis for the screening of FSGS in the future.http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2666;epage=2675;aulast=SongApoptosis; Coenzyme Q10 Monooxygenase 6 Mutation; Focal Segmental Glomerulosclerosis; Podocyte
spellingShingle Cheng-Cheng Song
Quan Hong
Xiao-Dong Geng
Xu Wang
Shu-Qiang Wang
Shao-Yuan Cui
Man-Di Guo
Ou Li
Guang-Yan Cai
Xiang-Mei Chen
Di Wu
New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient
Chinese Medical Journal
Apoptosis; Coenzyme Q10 Monooxygenase 6 Mutation; Focal Segmental Glomerulosclerosis; Podocyte
title New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient
title_full New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient
title_fullStr New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient
title_full_unstemmed New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient
title_short New Mutation of Coenzyme Q10 Monooxygenase 6 Causing Podocyte Injury in a Focal Segmental Glomerulosclerosis Patient
title_sort new mutation of coenzyme q10 monooxygenase 6 causing podocyte injury in a focal segmental glomerulosclerosis patient
topic Apoptosis; Coenzyme Q10 Monooxygenase 6 Mutation; Focal Segmental Glomerulosclerosis; Podocyte
url http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2666;epage=2675;aulast=Song
work_keys_str_mv AT chengchengsong newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT quanhong newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT xiaodonggeng newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT xuwang newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT shuqiangwang newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT shaoyuancui newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT mandiguo newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT ouli newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT guangyancai newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT xiangmeichen newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient
AT diwu newmutationofcoenzymeq10monooxygenase6causingpodocyteinjuryinafocalsegmentalglomerulosclerosispatient